Subjects affected by ApoA-I hereditary systemic amyloidosis are characterized by low levels of serum ApoA-I and HDLs; however, although they also present reduced levels of HDL cholesterol, patients do not show higher risk of developing CVD (15, 16, 17, 18). This evidence concerns the gene APOA1 and primary systemic amyloidosis.